Combunox Forest Laboratories, Inc. - Treatment for Moderate to Severe Pain
Combunox is a fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg) indicated for the short-term management of acute, moderate to severe pain. Forest expects to make Combunox available in the U.S. early next year.Posted: November 2004
Combunox (ibuprofen and oxycodone hydrochloride) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
